Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia

Classic congenital adrenal hyperplasia affects approximately 1 in 15,000 children. Current treatment strategies using multiple daily doses of hydrocortisone lead to suboptimal outcomes. We tested the hypothesis that nocturnal administration of dexamethasone will suppress the hypothalamic-pituitary-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dauber, Andrew, Feldman, Henry A., Majzoub, Joseph A.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943098/
https://www.ncbi.nlm.nih.gov/pubmed/20871859
http://dx.doi.org/10.1155/2010/347636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943098/
https://www.ncbi.nlm.nih.gov/pubmed/20871859
http://dx.doi.org/10.1155/2010/347636

Ejemplares similares